Skip to main content

Market Overview

Jefferies Initiates Auris Medical With Buy


Analysts at Jefferies initiated coverage on shares of Auris Medical (NASDAQ: EARS) with a Buy rating.

The target price for Auris Medical is set to $12.

Auris Medical's shares gained 0.82% to close at $6.15 on Friday.

Latest Ratings for EARS

Apr 2017Roth CapitalInitiates Coverage OnBuy
Mar 2016JefferiesMaintainsBuy
Sep 2014NeedhamInitiates Coverage OnBuy

View More Analyst Ratings for EARS
View the Latest Analyst Ratings


Related Articles (EARS)

View Comments and Join the Discussion!

Posted-In: JefferiesInitiation Analyst Ratings

Latest Ratings

SELFAegis CapitalInitiates Coverage On6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at